These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 3265855

  • 1. Action of 2'-deoxycoformycin on mitogen-induced lymphoproliferation in the neonatal period.
    Romo A, Lorente F, Salazar V.
    Allergol Immunopathol (Madr); 1988; 16(4):243-7. PubMed ID: 3265855
    [Abstract] [Full Text] [Related]

  • 2. 2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells.
    Ruers TJ, Buurman WA, van der Linden CJ.
    J Immunol; 1987 Jan 01; 138(1):116-22. PubMed ID: 3097141
    [Abstract] [Full Text] [Related]

  • 3. Action of deoxycoformycin on human T cell colonies in vitro.
    Colledge NR, Krajewski AS, Smyth JF, Wyllie AH.
    Clin Exp Immunol; 1982 Oct 01; 50(1):115-22. PubMed ID: 6983406
    [Abstract] [Full Text] [Related]

  • 4. Specificity of 2'-deoxycoformycin inhibition of adenosine metabolism in intact human skin fibroblasts.
    Holland MJ.
    Res Commun Chem Pathol Pharmacol; 1986 Mar 01; 51(3):311-24. PubMed ID: 3486439
    [Abstract] [Full Text] [Related]

  • 5. Role of adenosine deaminase in lymphocyte proliferation.
    Hovi T, Smyth JF, Allison AC, Williams SC.
    Clin Exp Immunol; 1976 Mar 01; 23(3):395-403. PubMed ID: 133008
    [Abstract] [Full Text] [Related]

  • 6. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
    Webster AD, Ip H, Pereira S.
    Clin Exp Immunol; 1982 Dec 01; 50(3):587-95. PubMed ID: 6299634
    [Abstract] [Full Text] [Related]

  • 7. Morphologic changes and immunohistochemical localization of adenosine deaminase in tissues of rats given injections of 2'-deoxycoformycin.
    Checkik BE, Perets A, SenGupta S, Fernandes B.
    J Natl Cancer Inst; 1983 Nov 01; 71(5):999-1010. PubMed ID: 6358608
    [Abstract] [Full Text] [Related]

  • 8. Specific immunosuppressive effects of constant infusion of 2'-deoxycoformycin.
    Trotta PP, Tedde A, Ikehara S, Pahwa R, Good RA, Balis ME.
    Cancer Res; 1981 Jun 01; 41(6):2189-96. PubMed ID: 6972248
    [Abstract] [Full Text] [Related]

  • 9. 2'-deoxycoformycin toxicity in murine spleen lymphocytes.
    Earle MF, Glazer RI.
    Mol Pharmacol; 1983 Jan 01; 23(1):165-70. PubMed ID: 6602939
    [No Abstract] [Full Text] [Related]

  • 10. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
    Ratech H, Kim J, Asofsky R, Thorbecke GJ, Hirschhorn R.
    J Immunol; 1984 Jun 01; 132(6):3077-84. PubMed ID: 6202772
    [Abstract] [Full Text] [Related]

  • 11. 2'-deoxycoformycin. A new anticancer agent.
    Poster DS, Penta JS, Bruno S, Macdonald JS.
    Cancer Clin Trials; 1981 Jun 01; 4(2):209-13. PubMed ID: 7018725
    [Abstract] [Full Text] [Related]

  • 12. Immune function in mice exposed to the adenosine deaminase inhibitor 2'-deoxycoformycin during immune system development.
    Luebke RW, Lawson LD, Rogers RR, Riddle MM, Smialowicz RJ.
    Immunopharmacol Immunotoxicol; 1987 Jun 01; 9(2-3):149-61. PubMed ID: 3501794
    [Abstract] [Full Text] [Related]

  • 13. Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
    Ho AD, Thaler J, Willemze R, Lauria F, Derossi G, Kuse R, Stryckmans P, Blanc CM, Cataldo F, McVie G.
    Bone Marrow Transplant; 1989 Jan 01; 4 Suppl 1():60-2. PubMed ID: 2653520
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
    Matsumoto SS, Yu J, Yu AL.
    J Immunol; 1983 Dec 01; 131(6):2762-6. PubMed ID: 6196398
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine.
    Grever MR, Siaw MF, Coleman MS, Whisler RL, Balcerzak SP.
    J Immunol; 1983 Jan 01; 130(1):365-9. PubMed ID: 6600187
    [No Abstract] [Full Text] [Related]

  • 16. Increased adenosine deaminase (ADA) activity and a shift from ADA-dependent to ADA-independent phases during T-cell activation: a paradox.
    Veit BC, Fishman M, Look T.
    J Natl Cancer Inst; 1984 May 01; 72(5):1151-9. PubMed ID: 6609265
    [Abstract] [Full Text] [Related]

  • 17. Effect of 2'-deoxycoformycin on erythroid, granulocytic, and T-lymphocyte colony growth.
    Aye MT, Dunne JV.
    Blood; 1981 Nov 01; 58(5):1043-6. PubMed ID: 6975136
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.